BRIEF: Pluristem plans secondary Nasdaq offering
Sep 13, 2012 (Globes - McClatchy-Tribune Information Services via COMTEX) -- Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) yesterday announced that it plans to hold a secondary offering of shares and warrants, on the basis of the shelf prospectus filed with the US Securities and Exchange Commission (SEC) in October 2011. The company did not announce the terms of the offering, including the price or number of shares and warrants to be offered.
Pluristem's share price fell 2.4 percent on Nasdaq yesterday, and a further 8.8 percent in after-hours trading, following the announcement, to $4.14, giving a market cap of $200 million. The TASE suspended trading in the share until the pricing of the offering, after the share price fell 7 percent to NIS 17.30 at the opening.
Pluristem will offer blocks of shares and warrants as units. The underwriters, Jefferies & Company Inc., Oppenheimer & Co. Inc., Needham & Company, LLC and Maxim Group LLC, will be offered over allotment options. Leader Capital Markets Ltd. is the company's financial adviser on the offering. |
